New pulse field ablation for new atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new device that uses pulsed electric fields to treat atrial fibrillation, a condition that causes an irregular heartbeat. The goal is to see if this approach safely and effectively restores a normal heart rhythm in people who have been recently diagnosed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been recently diagnosed with atrial fibrillation.
- You must not have had a prior procedure to treat the left upper chamber of your heart (left atrial ablation).
- You must be able to undergo this type of heart procedure.
- You must be at least 18 years old.
- You must agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study tests a new type of energy called pulsed field ablation to treat atrial fibrillation, an irregular heartbeat. It aims to see if it is safe and effective for people whose symptoms have not improved with medication.
This study tests a newer ablation technique using pulsed electrical energy to treat atrial fibrillation (an irregular heartbeat). You may qualify if you were recently diagnosed with AF and haven't had ablation before.
This trial tests a new method called pulsed field ablation (PFA) to treat irregular heartbeats (atrial fibrillation) by isolating the veins that carry blood to your heart. It aims to see how well this procedure works and if it's safe for you.
This study tests a new way to treat atrial fibrillation using targeted electrical pulses (pulsed field ablation) instead of heat or cold. The goal is to improve safety and outcomes for people with paroxysmal or persistent AF.
This trial tests a new way to treat non-paroxysmal atrial fibrillation (AF) using a focused type of ablation (pulsed-field energy) on specific areas of the heart. It aims to see if targeting the left atrial wall and mitral isthmus can improve outcomes for people who have not had this procedure before.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.